TLR2 Antibody (TL2.1)

Product Specs
ItemTLR2 Antibody (TL2.1) - BSA Free
CompanyNovus Biologicals, a Bio-Techne Brand
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberNB100-56722
Concentration1.0 mg/ml
PurityProtein G purified
Research AreaImmunology, Innate Immunity, Signal Transduction
Antibody TypePrimary Antibodies
StorageStore at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles
ReactivityHu, Ms, Rb, Rt, Ca
ClonalityMonoclonal
NCBI Gene AliasesTIL4, CD282
NCBI Full Gene Nametoll like receptor 2
ApplicationsWB, ELISA, FCM, ICC, IF, IP, DB, FA, Neut
ImmunogenThis antibody was raised by immunizing mice with CHO cells transfected with human TLR2 cDNA (PMID: 10657659). The hybridoma supernatants were selected by flow cytometry
HostMouse
CloneTL2.1
IsotypeIgG2a
TargetTLR2
FormatPBS
Conjugate/TagUnconjugated
Quantity0.1 mg (also 0.025 mg)
Brand/TrademarkNovus Biologicals, a Bio-Techne Brand

Available conjugates: Unconjugated

United States: 10771 E Easter Ave

Centennial, Colorado 80112

United States

Phone:
303-730-1950
888-506-6887

Email: novus@novusbio.com

(1) Efficacy of Rg1-Oil Adjuvant on Inducing Immune Responses against Bordetella bronchiseptica in RabbitsJournal of immunology researchJanuary 1, 2021Chenwen X, Quanan J, Yee H, Yan L, Jiaoyu W, Qiang W, Litao Q, Li N, Guolian B.

(5) CD89 Is a Potent Innate Receptor for Bacteria and Mediates Host Protection from SepsisCell reportsApril 16, 2019de Tymowski C, Heming N, Correia MDT, Abbad L, Chavarot N, Le Stang MB, Flament H, Bex J, Boedec E, Bounaix C, et al.

(6) Toll-like receptors blocking restores in vitro microbicidal activity in latent tuberculosis-infected subjectsThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung DiseaseFebruary 1, 2019Coelho da Silva FD, Covre LP, Stringari LL, Palaci M, Dietze R, Gomes DCO, Ribeiro-Rodrigues R.

(7) Oxidative Stress Induces Expression of the Toll-Like Receptors (TLRs) 2 and 4 in the Human Peripheral Blood Mononuclear Cells: Implications for Metabolic InflammationCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacologyJanuary 1, 2019Akhter N, Madhoun A, Arefanian H, Wilson A, Kochumon S, Thomas R, Shenouda S, Al-Mulla F, Ahmad R, Sindhu S.

(8) Role of whole saliva in the efficacy of sublingual immunotherapy in seasonal allergic rhinitisAllergology international : official journal of the Japanese Society of AllergologyJanuary 1, 2019Haruna T, Kariya S, Fujiwara T, Yuta A, Higaki T, Zhao P, Ogawa Y, Kanai K, Hirata Y, Oka A, et al.

(9) Toll-like receptor expression and apoptosis morphological patterns in female rat hearts with takotsubo syndrome induced by isoprenalineLife sciencesApril 15, 2018Kołodzińska A, Czarzasta K, Szczepankiewicz B, Główczyńska R, Fojt A, Ilczuk T, Budnik M, Krasuski K, Folta M, Cudnoch-Jędrzejewska A, et al.

(10) Substance P represents a novel first-line defense mechanism in the noseThe Journal of allergy and clinical immunologyJanuary 1, 2018Larsson O, Tengroth L, Xu Y, Uddman R, Kumlien Georén S, Cardell LO.

(11) ADAMTS5 Deficiency in Calcified Aortic Valves Is Associated With Elevated Pro-Osteogenic Activity in Valvular Interstitial CellsArteriosclerosis, thrombosis, and vascular biologyJuly 1, 2017Li F, Song R, Ao L, Reece TB, Cleveland JC Jr, Dong N, Fullerton DA, Meng X.

(13) NF-κB Links TLR2 and PAR1 to Soluble Immunomodulator Factor Secretion in Human PlateletsFrontiers in immunologyJanuary 1, 2017Damien P, Cognasse F, Payrastre B, Spinelli SL, Blumberg N, Arthaud CA, Eyraud MA, Phipps RP, McNicol A, Pozzetto B, et al.

(20) Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndromeClinical and experimental immunologyDecember 1, 2015Jamin A, Dehoux L, Dossier C, Fila M, Heming N, Monteiro RC, Deschênes G.

TLR2 Antibody (TL2.1) - BSA Free